Amylyx Pharmaceuticals, Inc. today announced the presentation of safety and tolerability data on AMX0035 (sodium phenylbutyrate [PB] and taurursodiol [TURSO; also known as ursodoxicoltaurine]) as assessed in the CENTAUR and PEGASUS clinical trials in participants with amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD), respectively. The data support the overall safety profile of AMX0035 as findings from this analysis show adverse event incidence was generally similar betwe

 iRhythm Technologies, Inc. a leading digital healthcare solutions company focused on the advancement of cardiac care, announces the results of three clinical research studies presented at The American College of Cardiology’s 71st Annual Scientific Session & Expo (ACC.22). The new clinical evidence: Further validates the Zio service as a viable solution for the early detection of atrial fibrillation (AF),1 helping undiagnosed populations effectively seek treatment bef

Babylon  today announced the integration of its AI-powered Symptom Checker technology into Higi’s mobile application, opening a new channel for proactive self-care health engagement for Higi’s thousands of U.S. app users. The integration follows Babylon’s recent acquisition of Higi, a consumer health engagement company whose platform and consumer reach is enabling Babylon to extend its highly scalable technology platform and digital-first healthcare solutions to Higi pl

The Hospital and Healthsystem Association of Pennsylvania (HAP) is recognizing four Pennsylvania health care teams for their exemplary projects addressing the unique needs of their communities during the COVID-19 pandemic. HAP’s COVID Response Innovation Awards showcase the innovative teams, solutions, and projects that have helped shape the health care community’s response to, understanding of, and resilience to the COVID-19 pandemic. “Pennsylvania hospi

Biome Analytics, the leading cardiovascular performance company, is pleased to introduce the Biome Opportunity Engine™. This groundbreaking solution enables cardiovascular service lines, at individual hospitals and health systems, to prioritize hundreds of improvement initiatives to lower cost, accelerate financial performance, and improve care. “The COVID pandemic forced many patients to delay care,” said Stuart Jacobson, CEO and founder of Biome Analytics. &ldquo

NexCore Group, a national healthcare real estate developer and investor, and HATCHspaces, LLC, a developer and operator of purpose-built life science real estate, announced a strategic platform to expand their portfolio of life sciences assets nationwide. The platform expansion will provide state-of-the-art labs, offices, manufacturing facilities, and other supporting facilities and infrastructure to the life science industry. With a focus on retaining key intellectual property and emerging t

Aidoc, the leading provider of healthcare AI solutions, today announced that it received FDA 510(k) clearance for its triage and notification of pneumothorax on X-ray exams. A one-stop partner for the enterprise's clinical AI needs, Aidoc's other seven FDA-cleared solutions are already implemented across U.S. health systems, flagging and communicating suspected pathologies in CT exams – and now have expanded to the high volume X-ray modality. Aidoc's newly FDA-clea

Tenax Therapeutics, Inc.  a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that two presentations will be made at the upcoming American College of Cardiology (ACC) Scientific Sessions featuring the Company’s lead drug candidates, imatinib and levosimendan, both of which are currently in late-stage development for the treatment of pulmona

Inherited cardiac conditions such as heart muscle or rhythm problems may be well known within families or only discovered after a family member dies unexpectedly. To detect and treat these diseases, Mayo Clinic Healthcare in London is adding inherited cardiac condition services including advanced imaging and electrocardiography (ECG) and genetic testing and counseling. Inherited cardiac conditions affect people of all ages and ethnicities, says Elijah Behr, M.D., a cardiologist at M

Yosi Health, a provider of digital patient scheduling, registration, payment, and communication cloud-based software solutions, announced today they have joined the Amazon Web Services (AWS) Partner Network (APN) as an Advanced Technology Partner. The APN is a global community of partners that leverage programs, expertise, and resources to build, market, and sell customer offerings. APN paves the way for service providers to reach a broader audience and build meaningful connections.